| Product Code: ETC13312511 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Drug Eluting Balloon Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Drug Eluting Balloon Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Drug Eluting Balloon Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Drug Eluting Balloon Market - Industry Life Cycle |
3.4 Europe Drug Eluting Balloon Market - Porter's Five Forces |
3.5 Europe Drug Eluting Balloon Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Drug Eluting Balloon Market Revenues & Volume Share, By Coating Type, 2021 & 2031F |
3.7 Europe Drug Eluting Balloon Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Europe Drug Eluting Balloon Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Europe Drug Eluting Balloon Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Drug Eluting Balloon Market Trends |
6 Europe Drug Eluting Balloon Market, 2021 - 2031 |
6.1 Europe Drug Eluting Balloon Market, Revenues & Volume, By Coating Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Drug Eluting Balloon Market, Revenues & Volume, By Paclitaxel-Eluting Balloons, 2021 - 2031 |
6.1.3 Europe Drug Eluting Balloon Market, Revenues & Volume, By Sirolimus-Eluting Balloons, 2021 - 2031 |
6.1.4 Europe Drug Eluting Balloon Market, Revenues & Volume, By Everolimus-Eluting Balloons, 2021 - 2031 |
6.1.5 Europe Drug Eluting Balloon Market, Revenues & Volume, By Zotarolimus-Eluting Balloons, 2020 - 2028 |
6.2 Europe Drug Eluting Balloon Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Drug Eluting Balloon Market, Revenues & Volume, By Coronary Artery Disease (CAD), 2021 - 2031 |
6.2.3 Europe Drug Eluting Balloon Market, Revenues & Volume, By Peripheral Artery Disease (PAD), 2021 - 2031 |
6.2.4 Europe Drug Eluting Balloon Market, Revenues & Volume, By In-Stent Restenosis (ISR), 2021 - 2031 |
6.2.5 Europe Drug Eluting Balloon Market, Revenues & Volume, By Bypass Graft Disease, 2021 - 2031 |
6.3 Europe Drug Eluting Balloon Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Drug Eluting Balloon Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Europe Drug Eluting Balloon Market, Revenues & Volume, By Cardiology Clinics, 2021 - 2031 |
6.3.4 Europe Drug Eluting Balloon Market, Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031 |
6.3.5 Europe Drug Eluting Balloon Market, Revenues & Volume, By Research Institutions, 2021 - 2031 |
7 Europe Drug Eluting Balloon Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Drug Eluting Balloon Market, Revenues & Volume, By Coating Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Drug Eluting Balloon Market, Revenues & Volume, By Coating Type, 2021 - 2031 |
7.2.2 Germany Drug Eluting Balloon Market, Revenues & Volume, By Coating Type, 2021 - 2031 |
7.2.3 France Drug Eluting Balloon Market, Revenues & Volume, By Coating Type, 2021 - 2031 |
7.2.4 Poland Drug Eluting Balloon Market, Revenues & Volume, By Coating Type, 2021 - 2031 |
7.2.5 Spain Drug Eluting Balloon Market, Revenues & Volume, By Coating Type, 2021 - 2031 |
7.2.6 Rest of Europe Drug Eluting Balloon Market, Revenues & Volume, By Coating Type, 2021 - 2031 |
7.3 Europe Drug Eluting Balloon Market Revenues & Volume Share, By Application, 2021 & 2031F |
7.3.1 United Kingdom (UK) Drug Eluting Balloon Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.2 Germany Drug Eluting Balloon Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.3 France Drug Eluting Balloon Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.4 Poland Drug Eluting Balloon Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.5 Spain Drug Eluting Balloon Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.6 Rest of Europe Drug Eluting Balloon Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4 Europe Drug Eluting Balloon Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 United Kingdom (UK) Drug Eluting Balloon Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Germany Drug Eluting Balloon Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 France Drug Eluting Balloon Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.4 Poland Drug Eluting Balloon Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.5 Spain Drug Eluting Balloon Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.6 Rest of Europe Drug Eluting Balloon Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Europe Drug Eluting Balloon Market Key Performance Indicators |
9 Europe Drug Eluting Balloon Market - Export/Import By Countries Assessment |
10 Europe Drug Eluting Balloon Market - Opportunity Assessment |
10.1 Europe Drug Eluting Balloon Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Drug Eluting Balloon Market Opportunity Assessment, By Coating Type, 2021 & 2031F |
10.3 Europe Drug Eluting Balloon Market Opportunity Assessment, By Application, 2021 & 2031F |
10.4 Europe Drug Eluting Balloon Market Opportunity Assessment, By End User, 2021 & 2031F |
11 Europe Drug Eluting Balloon Market - Competitive Landscape |
11.1 Europe Drug Eluting Balloon Market Revenue Share, By Companies, 2022 |
11.2 Europe Drug Eluting Balloon Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here